CD86 and COVID-19: Finally, in post-COVID-19 patients, the numbers of intermediate monocytes were lower than in acute patients but still significantly higher compared to healthy controls; post-COVID-19 monocytes also showed the highest expression of CCR2, CCR5, CD86, and HLA-DR together with the lowest expression of CD11b when compared to healthy controls [52].